# AminoChain

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aminochain

- Industry: Software
- Headquarters: New York, US
- Website: www.aminochain.io
- Total disclosed funding: $7.1M
- Latest round: Seed (Aug 16, 2024)
- Investors on record: 2

## About

Founded in 2022 and based in New York, US, AminoChain Inc. operates as a healthcare platform designed to streamline the management and sharing of biosamples and research data within the healthcare industry. In September 2024, AminoChain Inc. raised USD 5 million in seed funding led by new investor Andreessen Horowitz, with participation from another new investor Cercano Management. The round was part of a larger USD 7 million in equity funding.

AminoChain's primary product is a cloud-based platform that offers various features to support bio-sample and research data management. The company provides a biosample marketplace that connects biobanks and clinical sites with biopharma companies. The company’s platform is designed to streamline the management and sharing of biosamples across various healthcare companies.

The company will use the September 2024 funding to establish a decentralized biobank and layer 2 network.

## Funding rounds

- Seed, Aug 16, 2024, $7.1M — Andreessen Horowitz, Cercano Management

## Investors

- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Seed
- Cercano Management (https://capitalatlas.ai/funds/cercano-management) — Seed